$1,007,746,374

Funds epidemiology and laboratory capacity for detecting and controlling emerging infectious diseases across U.S. states.

Strengthens domestic disease surveillance and response infrastructure critical for pandemic preparedness and biosecurity.

Increases demand for diagnostic equipment, laboratory reagents, and bioinformatics systems from suppliers to state health departments.

Reduces U.S. dependence on foreign diagnostic capabilities and builds autonomous disease detection capacity amid biosecurity concerns.